S3 Episode 24: Reshaping the GLP-1 Economy: A Breaking Consumer Study

Link to episode:

Guest: Lisa W. Miller
Ex PepsiCo VP Consumer Strategy & Insights and founder of Lisa W. Miller & Associates

GLP-1 medications like Ozempic® and Wegovy® are transforming far more than weight loss. They’re changing how people eat, shop, spend money, dine out, and interact with brands, creating ripple effects across retail, restaurants, healthcare, apparel, and the broader economy.

In this episode, Aaron and Chino sit down with Lisa W. Miller, ex PepsiCo VP Consumer Strategy & Insights and founder of Lisa W. Miller & Associates, to discuss groundbreaking findings from her latest proprietary research on the rapidly evolving GLP-1 economy. With insights from more than 30 industry studies and a survey of 6,500 U.S. consumers, Lisa reveals what businesses need to know as consumer behavior changes in real time.

From the surprising rise of male GLP-1 users to the future of retail, employee benefits, and restaurant innovation, this conversation explores why companies that adapt early will likely have a competitive advantage while those that ignore these shifts risk being left behind.

What You’ll Learn

• How GLP-1 medications are reshaping consumer spending habits
• Why restaurants, retailers, and grocery brands are being forced to adapt
• The surprising growth of male GLP-1 adoption and why most brands are missing it
• Why simply labeling products “GLP-1 Friendly” isn’t enough
• How apparel companies and wedding retailers are responding to rapid weight loss
• The impact of GLP-1s on HR, employee benefits, and workplace policies
• The opportunities and risks businesses should prepare for over the next several years
• Why understanding consumer behavior matters more than following headlines.